Last reviewed · How we verify
NCT06987747
Reducing Pain in Complex Regional Pain Syndrome Using Personalized Brain Stimulation: A Feasibility Study
NA trial testing Repetitive transcranial magnetic stimulation in Complex Regional Pain Syndrome (CRPS) in 10 participants. Not yet recruiting.
31 December 2025
Quick facts
| Lead sponsor | McMaster University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 July 2025 |
| Primary completion | 31 December 2025 |
| Estimated completion | 1 February 2026 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Repetitive transcranial magnetic stimulation
Conditions studied
- Complex Regional Pain Syndrome (CRPS) — all drugs for Complex Regional Pain Syndrome (CRPS) →
Sponsor
McMaster University
Who can join
Adults 18 to 70, any sex, with Complex Regional Pain Syndrome (CRPS). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research study looks at the feasibility of using a new treatment, noninvasively activating the brain through repetitive transcranial magnetic stimulation (rTMS) to treat pain symptoms of complex regional pain syndrome (CRPS). This study will help us determine if this technique is feasible (able to recruit participants and if the research activities are feasible and can be used to treat CRPS patients with pain in a larger study. The investigators will also examine how TMS can be personalized to individuals using an individual's brain activity measured using EEG. The investigators will also study whether the effects of TMS are stronger if the TMS is delivered during a specific timing of the EEG activity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06987747
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Repetitive transcranial magnetic stimulation
Trials testing the same drug.
- NCT07531342 — Repetitive Transcranial Magnetic Stimulation Combined With Anti-inflammatory Diet in Crohn's Disease · NA · not yet recruiting
- NCT07210944 — Scalp Acupuncture Combined With rTMS for Upper Limb Motor Dysfunction in Stroke: A Brain Network Study · NA · not yet recruiting
- NCT07257601 — TDCS-RTMS Intervention for Motor Function · NA · not yet recruiting
- NCT07148388 — Accelerated Intermittent Theta Burst Stimulation (AiTBS)on Neuropathic Pain · NA · recruiting
- NCT06735157 — Repetitive Transcranial Magnetic Stimulation Paired with Augmented Reality to Alter Concussion Symptoms · NA · not yet recruiting
Other recruiting trials for Complex Regional Pain Syndrome (CRPS)
Currently open trials in the same condition.
- NCT03686748 — Two Point Discrimination · EARLY_PHASE1 · active not recruiting
Other McMaster University trials
Trials by the same sponsor.
- NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
- NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
- NCT07486505 — Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, M · NA · not yet recruiting
- NCT07408128 — Partner4Exercise Randomized Controlled Trial · Phase 2, PHASE3 · not yet recruiting
- NCT07459777 — Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anteri · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06987747 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by McMaster University
- Last refreshed: 23 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06987747.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing